$4.15 Billion is the total value of RTW INVESTMENTS, LP's 90 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 40.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RCKT | Rocket Pharmaceuticals Inc | $384,334,000 | +9.2% | 16,812,491 | 0.0% | 9.25% | -6.5% | |
| IMVT | Buy | Immunovant Inc | $264,291,000 | +89.8% | 7,510,412 | +31.4% | 6.36% | +62.5% |
| ALNY | Alnylam Pharmaceuticals Inc | $244,848,000 | -1.7% | 1,681,645 | 0.0% | 5.90% | -15.9% | |
| PTCT | Buy | PTC Therapeutics Inc | $186,686,000 | -7.2% | 3,993,286 | +0.8% | 4.50% | -20.5% |
| MRTX | Buy | Mirati Therapeutics Inc | $181,992,000 | +46.5% | 1,096,005 | +0.8% | 4.38% | +25.4% |
| DRNA | Buy | Dicerna Pharmaceuticals Inc | $130,021,000 | -28.4% | 7,227,413 | +1.0% | 3.13% | -38.8% |
| MYOK | Myokardia Inc | $127,732,000 | +41.1% | 936,931 | 0.0% | 3.08% | +20.7% | |
| NTRA | Buy | Natera Inc | $123,586,000 | +62.1% | 1,710,769 | +11.9% | 2.98% | +38.7% |
| AXSM | Buy | Axsome Therapeutics Inc | $119,054,000 | -12.7% | 1,670,938 | +0.8% | 2.87% | -25.3% |
| STOK | Stoke Therapeutics Inc | $118,697,000 | +40.5% | 3,544,248 | 0.0% | 2.86% | +20.3% | |
| RNA | Avidity Biosciences Inc | $109,888,000 | +5.8% | 3,995,000 | 0.0% | 2.65% | -9.4% | |
| MASI | Buy | Masimo Corp | $106,319,000 | +19.9% | 450,390 | +15.8% | 2.56% | +2.6% |
| CERN | Buy | Cerner Corp | $100,631,000 | +24.2% | 1,392,049 | +17.7% | 2.42% | +6.3% |
| AXNX | Buy | Axonics Modulation Technologies Inc | $96,152,000 | +45.4% | 1,883,864 | +0.0% | 2.32% | +24.5% |
| BAX | Buy | Baxter International Inc | $86,634,000 | +3.8% | 1,077,268 | +11.1% | 2.09% | -11.2% |
| TXG | Buy | 10x Genomics Inc | $82,405,000 | +45.1% | 660,933 | +3.9% | 1.98% | +24.2% |
| ADVM | Buy | Adverum Biotechnologies Inc | $74,518,000 | -47.4% | 7,234,764 | +6.5% | 1.79% | -55.0% |
| VCEL | Buy | Vericel Corp | $71,356,000 | +34.1% | 3,850,851 | +0.0% | 1.72% | +14.8% |
| TNDM | Buy | Tandem Diabetes Care Inc | $68,495,000 | +15.6% | 603,481 | +0.8% | 1.65% | -1.1% |
| PTGX | Buy | Protagonist Therapeutics Inc | $66,645,000 | +11.5% | 3,408,961 | +0.8% | 1.60% | -4.5% |
| RLMD | Buy | Relmada Therapeutics Inc | $56,857,000 | -14.2% | 1,511,337 | +2.1% | 1.37% | -26.6% |
| ILMN | New | Illumina Inc | $54,089,000 | – | 175,000 | +100.0% | 1.30% | – |
| GH | New | Guardant Health Inc | $52,480,000 | – | 469,498 | +100.0% | 1.26% | – |
| AGEN | Agenus Inc | $51,459,000 | +1.8% | 12,864,677 | 0.0% | 1.24% | -12.9% | |
| TBIO | Buy | Translate Bio Inc | $50,973,000 | -23.5% | 3,745,286 | +0.8% | 1.23% | -34.5% |
| FREQ | Buy | Frequency Therapeutics Inc | $47,285,000 | -5.9% | 2,461,486 | +13.9% | 1.14% | -19.5% |
| CLDX | Buy | Celldex Therapeutics Inc | $46,272,000 | +36.4% | 3,120,137 | +19.5% | 1.11% | +16.6% |
| ATHA | New | Athira Pharma Inc | $45,372,000 | – | 2,668,913 | +100.0% | 1.09% | – |
| ESTA | Establishment Labs Holdings Inc | $42,974,000 | -0.8% | 2,319,138 | 0.0% | 1.04% | -15.1% | |
| NSTG | NanoString Technologies Inc | $42,337,000 | +52.3% | 947,134 | 0.0% | 1.02% | +30.3% | |
| CYTK | New | Cytokinetics Inc Private | $40,702,000 | – | 2,000,000 | +100.0% | 0.98% | – |
| OYST | Buy | Oyster Point Pharma Inc | $40,613,000 | -26.3% | 1,923,893 | +0.8% | 0.98% | -36.9% |
| CSTL | Sell | Castle Biosciences Inc | $38,260,000 | +26.3% | 743,642 | -7.5% | 0.92% | +8.1% |
| ISEE | Buy | IVERIC bio Inc | $37,582,000 | +11.7% | 6,663,439 | +1.0% | 0.90% | -4.3% |
| Buy | DermTech Inc | $34,502,000 | -8.7% | 2,887,215 | +1.1% | 0.83% | -21.8% | |
| MIST | Milestone Pharmaceuticals Inc | $31,587,000 | +93.7% | 4,315,102 | 0.0% | 0.76% | +65.8% | |
| MGNX | Buy | MacroGenics Inc | $31,621,000 | -9.1% | 1,255,299 | +0.8% | 0.76% | -22.3% |
| New | Trillium Therapeutics Inc | $30,705,000 | – | 2,160,800 | +100.0% | 0.74% | – | |
| INCY | New | Incyte Corp | $29,986,000 | – | 334,144 | +100.0% | 0.72% | – |
| AVDL | Buy | Avadel Pharmaceuticals plcsponsored adr | $27,048,000 | -36.9% | 5,366,705 | +1.1% | 0.65% | -46.0% |
| FIXX | Sell | Homology Medicines Inc | $26,942,000 | -59.2% | 2,517,906 | -42.1% | 0.65% | -65.1% |
| OSUR | Buy | OraSure Technologies Inc | $25,254,000 | +40.9% | 2,075,082 | +34.7% | 0.61% | +20.6% |
| PRQR | Buy | ProQR Therapeutics NV | $23,822,000 | -20.1% | 4,973,174 | +1.4% | 0.57% | -31.6% |
| VXRT | New | Vaxart Inc | $23,390,000 | – | 3,517,345 | +100.0% | 0.56% | – |
| BLI | New | Berkeley Lights Inc | $22,934,000 | – | 300,338 | +100.0% | 0.55% | – |
| TELA | Buy | Tela Bio Inc | $22,805,000 | +29.0% | 1,378,776 | +1.1% | 0.55% | +10.5% |
| JNJ | Buy | Johnson & Johnson | $22,296,000 | +25.0% | 149,761 | +18.1% | 0.54% | +7.0% |
| ITOS | New | Iteos Therapeutics Inc | $20,904,000 | – | 902,855 | +100.0% | 0.50% | – |
| ADAP | Buy | Adaptimmune Therapeutics PLCsponds adr | $20,889,000 | -19.7% | 2,617,626 | +0.7% | 0.50% | -31.3% |
| OM | New | Outset Medical Inc | $20,250,000 | – | 405,000 | +100.0% | 0.49% | – |
| ABUS | Sell | Arbutus Biopharma Corp | $18,712,000 | +49.7% | 5,978,355 | -13.0% | 0.45% | +28.1% |
| PMVP | New | Pmv Pharmaceuticals Inc | $17,750,000 | – | 500,000 | +100.0% | 0.43% | – |
| ALT | New | Altimmune Inc | $17,621,000 | – | 1,334,940 | +100.0% | 0.42% | – |
| MDXG | MiMedx Group Inc | $17,161,000 | +17.7% | 2,700,320 | 0.0% | 0.41% | +0.7% | |
| IMUX | New | Immunic Inc | $16,945,000 | – | 912,496 | +100.0% | 0.41% | – |
| APYX | Apyx Medical Corp | $15,973,000 | -15.1% | 3,391,279 | 0.0% | 0.38% | -27.4% | |
| AMRS | Buy | Amyris Inc | $15,071,000 | +21.5% | 5,161,347 | +66.3% | 0.36% | +4.0% |
| XGN | Sell | Exagen Inc | $13,551,000 | -13.0% | 1,250,131 | -0.4% | 0.33% | -25.6% |
| AFIB | New | Acutus Medical Inc | $13,465,000 | – | 451,834 | +100.0% | 0.32% | – |
| ODT | Buy | Odonate Therapeutics Inc | $13,420,000 | -34.1% | 999,256 | +107.7% | 0.32% | -43.6% |
| GNMK | Sell | GenMark Diagnostics Inc | $10,835,000 | -21.2% | 762,994 | -18.4% | 0.26% | -32.6% |
| ARCT | New | Arcturus Therapeutics Ltd | $10,778,000 | – | 251,236 | +100.0% | 0.26% | – |
| CTMX | Buy | Cytomx Therapeutics Inc | $10,148,000 | -19.6% | 1,526,003 | +0.8% | 0.24% | -31.3% |
| LJPC | Buy | La Jolla Pharmaceutical Co | $9,652,000 | -4.6% | 2,395,029 | +0.8% | 0.23% | -18.6% |
| BLU | Sell | Bellus Health Inc | $9,547,000 | -84.5% | 4,195,356 | -29.7% | 0.23% | -86.7% |
| ITMR | Itamar Medical Ltdsponsored ads | $9,341,000 | +9.8% | 457,218 | 0.0% | 0.22% | -5.9% | |
| FULC | New | Fulcrum Therapeutics Inc | $9,124,000 | – | 1,150,565 | +100.0% | 0.22% | – |
| INMD | Inmode Ltd | $9,045,000 | +27.8% | 250,000 | 0.0% | 0.22% | +9.5% | |
| RGNX | Buy | Regenxbio Inc | $8,763,000 | -24.7% | 318,434 | +0.8% | 0.21% | -35.5% |
| ARGX | argenx SEsponsored adr | $8,336,000 | +16.6% | 31,752 | 0.0% | 0.20% | 0.0% | |
| RACA | New | Therapeutics Acquisition Corp | $7,046,000 | – | 490,000 | +100.0% | 0.17% | – |
| TMDX | Transmedics Group Inc | $6,935,000 | -23.1% | 503,266 | 0.0% | 0.17% | -34.3% | |
| LSACU | Lifesci Acquisition Corpunit 03/31/2025 | $6,800,000 | +23.6% | 500,000 | 0.0% | 0.16% | +5.8% | |
| BWAY | Brainsway Ltdsponsored ads | $6,459,000 | -1.5% | 1,107,420 | 0.0% | 0.16% | -15.2% | |
| BCTG | New | BCTG Acquisition Corp | $6,216,000 | – | 600,000 | +100.0% | 0.15% | – |
| CLSD | Buy | Clearside Biomedical Inc | $6,079,000 | -17.5% | 3,947,518 | +0.8% | 0.15% | -29.5% |
| QURE | Buy | Uniqure NV | $5,837,000 | -17.6% | 158,479 | +0.8% | 0.14% | -29.1% |
| EQ | New | Equillium Inc | $5,798,000 | – | 1,004,784 | +100.0% | 0.14% | – |
| PSNL | Personalis Inc | $5,526,000 | +67.1% | 255,000 | 0.0% | 0.13% | +43.0% | |
| ARYBU | Arya Sciences Acquisition II Corpunit 06/09/2027 | $5,500,000 | -5.1% | 500,000 | 0.0% | 0.13% | -19.0% | |
| ARYA | New | Arya Sciences Acquisition Corp | $5,408,000 | – | 500,000 | +100.0% | 0.13% | – |
| PROF | Buy | Profound Medical Corp | $4,308,000 | +46.0% | 244,193 | +40.2% | 0.10% | +25.3% |
| PHGE | Biomx Inc | $3,804,000 | +14.9% | 600,000 | 0.0% | 0.09% | -1.1% | |
| IMTX | New | Immatics Nv | $3,714,000 | – | 350,000 | +100.0% | 0.09% | – |
| PANAU | New | Panacea Acquisition Corpunit 99/99/9999 | $3,600,000 | – | 300,000 | +100.0% | 0.09% | – |
| CHAQU | Chardan Healthcare Acquisition 2 Corpunit 99/99/9999 | $3,588,000 | -2.4% | 350,000 | 0.0% | 0.09% | -16.5% | |
| PROG | Progenity Inc | $2,481,000 | +0.2% | 275,000 | 0.0% | 0.06% | -14.3% | |
| TWST | Twist Bioscience Corp | $1,403,000 | +67.6% | 18,473 | 0.0% | 0.03% | +41.7% | |
| BNR | Burning Rock Biotech Ltdsponsored ads | $752,000 | -7.2% | 30,000 | 0.0% | 0.02% | -21.7% | |
| PHGEWS | BiomX Equities Warrant Exp 13 Dec 2023*w exp 10/16/202 | $426,000 | +48.4% | 600,000 | 0.0% | 0.01% | +25.0% | |
| VRAY | Exit | Viewray Inc | $0 | – | -150,000 | -100.0% | -0.01% | – |
| MOTS | Exit | Motus Gi Hldgs Inc | $0 | – | -775,640 | -100.0% | -0.03% | – |
| FLGT | Exit | Fulgent Genetics Inc | $0 | – | -75,000 | -100.0% | -0.03% | – |
| NARI | Exit | Inari Med Inc | $0 | – | -44,860 | -100.0% | -0.06% | – |
| ARVN | Exit | Arvinas Inc | $0 | – | -174,118 | -100.0% | -0.16% | – |
| RPTX | Exit | Repare Therapeutics Inc | $0 | – | -225,000 | -100.0% | -0.20% | – |
| NEO | Exit | Neogenomics Inc | $0 | – | -445,000 | -100.0% | -0.39% | – |
| STAA | Exit | STAAR Surgical Co | $0 | – | -308,904 | -100.0% | -0.54% | – |
| WVE | Exit | WAVE Life Sciences Ltd | $0 | – | -2,390,496 | -100.0% | -0.70% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.